Home | News | Find a Doctor | Ask a Question | Free

TrichoScience


#1

Small article on TrichoScience.

http://www.marketwatch.com/story/newcastle-announces-entry-into-share-exchange-agreement-with-trichoscience-innovations-inc-2010-10-29?reflink=MW_news_stmp


#2

» Small article on TrichoScience.
»
» http://www.marketwatch.com/story/newcastle-announces-entry-into-share-exchange-agreement-with-trichoscience-innovations-inc-2010-10-29?reflink=MW_news_stmp

Interesting I guess, but I’ll be happier when these guys start meeting milestones.


#3

What Iron_Man would think about this. Because he’s a widely known wise person on hair loss world so maybe he can bring us some light.


#4

» Small article on TrichoScience.
»
» http://www.marketwatch.com/story/newcastle-announces-entry-into-share-exchange-agreement-with-trichoscience-innovations-inc-2010-10-29?reflink=MW_news_stmp

I think there are good things on the horizon for this company. Someone must be convinced enough to put a million in committing to two more. Good things on the horizon here I think. I just wonder if and when they will start the trials. Anyone know?


#5

» » Small article on TrichoScience.
» »
» »
» http://www.marketwatch.com/story/newcastle-announces-entry-into-share-exchange-agreement-with-trichoscience-innovations-inc-2010-10-29?reflink=MW_news_stmp
» ----------
» I think there are good things on the horizon for this company. Someone
» must be convinced enough to put a million in committing to two more. Good
» things on the horizon here I think. I just wonder if and when they will
» start the trials. Anyone know?

Whoever the guy @ZZ is - he knows what he is talking about …

·ZZ - 11/25/10 10:16 am
It’s all speculation from a distance. On the one hand, it could mean that those on the inside (the core research group + investors) have extreme confidence from what they have seen and this is their public platform for moving forward.

Matt Wayrynen, the former CEO of Tricho, who held that position b/c of his fundraising ability, is also the CEO of Berkely Resources, Inc., (Oil/Natural Gas company). In Sept., Berkely bought 200,000 shares of Tricho. Now Newcastle Resources, Ltd. (a mining company) is the vehicle to take the shares public and will change its name to Replicel Life Sciences, Inc. Wayrynen is on the board or CEO of at least 9 different mining/mineral/gold/petroleum companies so you would have to assume there is a connection but I’m not sure of the significance other than to presume he is extremely bullish on Tricho. Supposedly, Tricho was fully funded over a year ago (Sept. 2009) and this new agreement calls for an additional 3 mil of funding. Unlike a typical IPO, it does not appear that the insider group will immediately benefit from the public format. Newcastle is little more than a shell w/ little revenue and is lightly traded. Prior to this announcement it was trading at about 20 cents a share but it’s now at about $1.35. My guess is that it will fall back down if the deal closes (Nov 30th) and Newcastle issues 44 million shares to existing Tricho shareholders which would dilute the stock value.

On the other hand, Wayrynen seems to know how to make money and they could be hedging their bets. A privately held company can only make money if it produces revenue. However, a publicly held company can make money just by investors thinking the company will make money. If the deal closes and Tricho becomes a publically traded stock, it could go up on positive but not necessarily breakthru information that would lead to actual revenue. Time will tell. I just wish they would get their clinical trial going!

Especially in this scene, it’s sometimes pretty easy to make money - with just a carrot in front of investors nose. The head-guys behind TrichoScience just waited comfortable (nearly 10 years, since they filled their patent), to find out (for free) how OTHERS (Gho/ARI etc) solve all the serious problems (consistency, manufacturing etc) behind this science.
On the other hand, for hair loss sufferers it doesn’t matter “who-did-when-how-what” as long as an acceptable and effective “cure” against hair loss is available out there.


#6
  • double post -

#7

» » » Small article on TrichoScience.
» » »
» » »
» »
» http://www.marketwatch.com/story/newcastle-announces-entry-into-share-exchange-agreement-with-trichoscience-innovations-inc-2010-10-29?reflink=MW_news_stmp
» » ----------
» » I think there are good things on the horizon for this company. Someone
» » must be convinced enough to put a million in committing to two more.
» Good
» » things on the horizon here I think. I just wonder if and when they will
» » start the trials. Anyone know?
»
» Whoever the guy @ZZ is - he knows what he is talking about …
» ----------------------------
» ·ZZ - 11/25/10 10:16 am
» It’s all speculation from a distance. On the one hand, it could mean that
» those on the inside (the core research group + investors) have extreme
» confidence from what they have seen and this is their public platform for
» moving forward.
»
» Matt Wayrynen, the former CEO of Tricho, who held that position b/c of his
» fundraising ability, is also the CEO of Berkely Resources, Inc.,
» (Oil/Natural Gas company). In Sept., Berkely bought 200,000 shares of
» Tricho. Now Newcastle Resources, Ltd. (a mining company) is the vehicle to
» take the shares public and will change its name to Replicel Life Sciences,
» Inc. Wayrynen is on the board or CEO of at least 9 different
» mining/mineral/gold/petroleum companies so you would have to assume there
» is a connection but I’m not sure of the significance other than to presume
» he is extremely bullish on Tricho. Supposedly, Tricho was fully funded over
» a year ago (Sept. 2009) and this new agreement calls for an additional 3
» mil of funding. Unlike a typical IPO, it does not appear that the insider
» group will immediately benefit from the public format. Newcastle is little
» more than a shell w/ little revenue and is lightly traded. Prior to this
» announcement it was trading at about 20 cents a share but it’s now at about
» $1.35. My guess is that it will fall back down if the deal closes (Nov
» 30th) and Newcastle issues 44 million shares to existing Tricho
» shareholders which would dilute the stock value.
»
» On the other hand, Wayrynen seems to know how to make money
» and they could be hedging their bets. A privately held company can only
» make money if it produces revenue. However, a publicly held company can
» make money just by investors thinking the company will make money. If the
» deal closes and Tricho becomes a publically traded stock, it could go up on
» positive but not necessarily breakthru information that would lead to
» actual revenue.
Time will tell. I just wish they would get
» their clinical trial going!
» ----------------------------
»
» Especially in this scene, it’s sometimes pretty easy to make money - with
» just a carrot in front of investors nose. The head-guys behind
» TrichoScience just waited comfortable (nearly 10 years, since they filled
» their patent), to find out (for free) how OTHERS (Gho/ARI etc) solve all
» the serious problems (consistency, manufacturing etc) behind this science.
» On the other hand, for hair loss sufferers it doesn’t matter
» “who-did-when-how-what” as long as an acceptable and effective “cure”
» against hair loss is available out there.

Interesting views. Who would invest 3M in a company like this if they didn’t have some sort of validation of the process and results? Especially when it’s a complete departure from their traditional business operations.


#8

» Interesting views. Who would invest 3M in a company like this if they
» didn’t have some sort of validation of the process and results? Especially
» when it’s a complete departure from their traditional business operations.

Once again the main subject …

» However, a publicly held company can make money just by
» investors thinking the company will make money. If the
» deal closes and Tricho becomes a publically traded stock, it could go up on
» positive but not necessarily breakthru information that would lead to
» actual revenue.


#9

» » Interesting views. Who would invest 3M in a company like this if they
» » didn’t have some sort of validation of the process and results?
» Especially
» » when it’s a complete departure from their traditional business
» operations.
»
» Once again the main subject …
»
» » However, a publicly held company can make money just
» by

» » investors thinking the company will make
» money.
If the
» » deal closes and Tricho becomes a publically traded stock, it could go up
» on
» » positive but not necessarily breakthru information that would lead to
» » actual revenue.

Yes and once again, would you put $3M into a company thinking you’re going to make a bunch of money on speculation given today’s volatile market conditions. I really think you’re an opinionated person who really bases theories on lack of facts. It would be nice if you could have a fact based discussion with you but I feel you don’t have any of the facts.


#10

Whatthefück, how many shares did YOU bought from this air-acrobatics ?

If none, you still have 2 days …


#11

» Whatthefück, how many shares did YOU bought from this air-acrobatics ?
»
» If none, you still have 2 days …

2 days before what? I don’t own any shares in this. Not something I’d be investing in. I just want to get my hair back and have a good solution.


#12

» Small article on TrichoScience.
»
» http://www.marketwatch.com/story/newcastle-announces-entry-into-share-exchange-agreement-with-trichoscience-innovations-inc-2010-10-29?reflink=MW_news_stmp

The investor, Newcastle Resources Ltd, is a Vancouver based over the counter traded stock. I wouldn’t get too excited…